-BioMarin Presents Findings from Studies of Valoctocogene Roxaparvovec, Investigational Gene Therapy, at the International Society on Thrombosis and Haemostasis (ISTH) 2022 Congress

Media coverage

• Title	-BioMarin Presents Findings from Studies of Valoctocogene Roxaparvovec, Investigational Gene Therapy, at the International Society on Thrombosis and Haemostasis (ISTH) 2022 Congress
  Media name/outlet	M2 PressWIRE
  Country/Territory	United States
  Date	12/07/22
  Persons	Suresh Agarwal

• Title	-BioMarin Presents Findings from Studies of Valoctocogene Roxaparvovec, Investigational Gene Therapy, at the International Society on Thrombosis and Haemostasis (ISTH) 2022 Congress
  Media name/outlet	ENP Newswire
  Country/Territory	United Kingdom
  Date	12/07/22
  Persons	Suresh Agarwal